Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527689) titled 'Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ruijin Hospital
Condition:
Breast Cancer
Intervention:
Radiation: Ultra-hypofractionated Regional Nodal Irradiation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 30, 2026
Target Sample Size: 1950
Countries of Recruitment:
China
To know more, visit https://clinicaltr...